These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9232077)
41. Restenosis after PTCA. Assali A; Beigel Y Isr J Med Sci; 1995 Jun; 31(6):377-81. PubMed ID: 7607862 [No Abstract] [Full Text] [Related]
42. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. Nobuyoshi M; Kimura T; Ohishi H; Horiuchi H; Nosaka H; Hamasaki N; Yokoi H; Kim K J Am Coll Cardiol; 1991 Feb; 17(2):433-9. PubMed ID: 1991900 [TBL] [Abstract][Full Text] [Related]
43. Apples, oranges, and restenosis. Heller LI Circulation; 1995 Jan; 91(2):562. PubMed ID: 7805265 [No Abstract] [Full Text] [Related]
44. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486 [TBL] [Abstract][Full Text] [Related]
45. [The therapeutic options in postangioplasty coronary restenosis. The viewpoint of a surgeon]. González Santos JM Rev Esp Cardiol; 1995 Jan; 48(1):30-5. PubMed ID: 7878279 [No Abstract] [Full Text] [Related]
46. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Gravanis MB; Roubin GS Hum Pathol; 1989 May; 20(5):477-85. PubMed ID: 2523334 [TBL] [Abstract][Full Text] [Related]
48. Perspectives of arterial gene therapy for the prevention of restenosis. Feldman LJ; Tahlil O; Steg G Cardiovasc Res; 1996 Aug; 32(2):194-207. PubMed ID: 8796105 [TBL] [Abstract][Full Text] [Related]
49. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. Forrester JS; Fishbein M; Helfant R; Fagin J J Am Coll Cardiol; 1991 Mar; 17(3):758-69. PubMed ID: 1993798 [TBL] [Abstract][Full Text] [Related]
50. Anticoagulation and restenosis after percutaneous transluminal coronary angioplasty. Bettmann MA Am J Cardiol; 1987 Jul; 60(3):17B-19B. PubMed ID: 2956835 [TBL] [Abstract][Full Text] [Related]
51. The urge to prevent restenosis after percutaneous transluminal coronary angioplasty. Scylla and Charybdis in disguise. Becker AE Circulation; 1992 Apr; 85(4):1632-3. PubMed ID: 1313345 [No Abstract] [Full Text] [Related]
53. The experimental animal models for assessing treatment of restenosis. Kantor B; Ashai K; Holmes DR; Schwartz RS Cardiovasc Radiat Med; 1999; 1(1):48-54. PubMed ID: 11272356 [TBL] [Abstract][Full Text] [Related]
54. Vessel size, antioxidants, and restenosis: never too small, not too little, but often too late. Edelman ER Circulation; 1998 Feb; 97(5):416-20. PubMed ID: 9490233 [No Abstract] [Full Text] [Related]
55. Intimal disruption and coronary thrombosis: its role in the pathogenesis of human coronary disease. Forrester J Am J Cardiol; 1991 Sep; 68(7):69B-77B. PubMed ID: 1892070 [No Abstract] [Full Text] [Related]
56. [Methods of induction of a coronary thrombosis by means of direct current in the closed dog and dwarf swine thorax]. Sedlarik K; Wilde J; Eger H; Reimann G; Schilling B; Vollmar F; Fiehring H; Seelig G; Schreiber U; Sperling HD; Schreiter E Z Exp Chir; 1977 Jun; 10(3):145-55. PubMed ID: 899091 [TBL] [Abstract][Full Text] [Related]
57. The restenosis "antitheory". Topol EJ Mayo Clin Proc; 1993 Jan; 68(1):88-90. PubMed ID: 8417263 [No Abstract] [Full Text] [Related]
58. [The "preconditioning" phenomenon. Experimental and clinical aspects]. De Servi S; Mariani G G Ital Cardiol; 1991 Aug; 21(8):833-7. PubMed ID: 1769449 [No Abstract] [Full Text] [Related]